Also found in: Dictionary, Thesaurus, Medical.
LGMDLimb-Girdle Muscular Dystrophy
LGMDLobula Giant Movement Detector (computational biology)
LGMDLocal Government Monitoring Database (Tanzania)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Some previous researchs have suggested that L-CMD may progress to EDMD or LGMD1B.[11],[17] At the level of the lower leg, we also found that L-CMD, EDMD, and LGMD displayed similar changes.
In this report, we identified by whole-exome sequencing a compound heterozygous mutations in TRAPPC11 (AK022778.1), i.e., c.1192C>T (p.Arg398*) and c.3014C>T (p.Pro1005Leu), in two affected members of a Chinese family with LGMD. Previous findings include the whole-exome sequencing combined with linkage analysis of a Syrian family with limb girdle muscular dystrophy type 2S (LGMD2S;OMIM#615356).
LGMD is characterized by progressive weakness of proximal muscles such as those of the hip or shoulder and was first proposed as a nosological entity by Walton and Nattrass in 1954 [1].
The remaining one patient had complete presence of membranous staining but of weak intensity hence diagnosed as LGMD.
Thus, there is ample opportunity for researchers to explore the experiences of individuals and families living with MG and other muscular dystrophies such as LGMD, FSHD, and OPMD.
Among the 32 cases, 9 (28.12%) were females who showed the clinical, biochemical and morphological features of DMD (n = 5; 55.5%), BMD (n = 3; 33.3%) and LGMD (n = 1; 11.11%).
Limb girdle muscular dystrophy (LGMD) is a genetically heterogeneous disease that may be autosomal recessive (2A-J) or autosomal dominant (1A-1F) (1-2).
To build up a picture of how the LGMD neuron works the University of Newcastle researchers showed a locust dogfight battle scenes from Star Wars while monitoring the neuron's activity.
LGMD can begin in childhood, adolescence, young adulthood or even later.
Mayur suffers from a severe muscle-wasting disease, Limb Girdle Muscular Dystrophy (LGMD).
Investors have mostly focused on m-dystrophin in Duchenne muscular dystrophy, or DMD, but he believes its pipeline in limb-girdle muscular dystrophy, or LGMD, is not yet fully reflected in the current valuation and thinks catalysts from LGMD will drive upside in the back half of 2019, Ahmad tells investors.
In LGMD type 2E, disease usually occurs before age 10, progresses to loss of ambulation in the teen years, and often leads to death before age 30.